PROZYMI BIOLABS LTDActive
Key figures
Like most small UK companies, PROZYMI BIOLABS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025/26Balance sheet structure
Filed accounts2021/22–2025/26
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Profit for the year | 0 | — | — | — | — |
| Cash at bank and in hand | 15,010 | — | — | — | — |
| Total assets | 15,010 | 31,206 | 42,830 | 47,026 | 88,484 |
| Total liabilities | 15,008 | 15,751 | 43,993 | 54,373 | 41,713 |
| Net assets / total equity | 2 | -1,878 | -12,792 | -492 | 43,464 |
| Average number of employees | 0 | 3 | 3 | 3 | 3 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: PROZYMI BIOLABS LTD
Company
PROZYMI BIOLABS LTD is a private limited company registered with Companies House under company number SC688453. It was incorporated on 8 Feb 2021. Its status is active. The registered office is in Edinburgh (EH8). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2025/26 (period ending 28 Feb 2026); the company files micro-entity accounts. Net assets were £43,464, up 8,934.1% on the previous year. Total assets were £88,484 and total liabilities £41,713. The company had an average of 3 employees. Figures are available for 5 financial years (2021/22–2025/26).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 30 Nov 2027. The next confirmation statement is due by 21 Feb 2027.